Heart failure causes sleepless nights

Harvey Davis,David Attwell

DOI: https://doi.org/10.1126/science.adj0217

IF: 56.9

2023-07-21

Science

Abstract:Cardiac dysfunction triggers immune-mediated loss of pineal gland melatonin release

multidisciplinary sciences

What problem does this paper attempt to address?

Immune-mediated denervation of the pineal gland underlies sleep disturbance in cardiac disease

Karin A Ziegler,Andrea Ahles,Anne Dueck,Dena Esfandyari,Pauline Pichler,Karolin Weber,Stefan Kotschi,Alexander Bartelt,Inga Sinicina,Matthias Graw,Heinrich Leonhardt,Ludwig T Weckbach,Steffen Massberg,Martina Schifferer,Mikael Simons,Luciano Hoeher,Jie Luo,Ali Ertürk,Gabriele G Schiattarella,Yassine Sassi,Thomas Misgeld,Stefan Engelhardt,Karin A. Ziegler,Ludwig T. Weckbach,Gabriele G. Schiattarella

DOI: https://doi.org/10.1126/science.abn6366

IF: 56.9

2023-07-21

Science

Abstract:Disruption of the physiologic sleep-wake cycle and low melatonin levels frequently accompany cardiac disease, yet the underlying mechanism has remained enigmatic. Immunostaining of sympathetic axons in optically cleared pineal glands from humans and mice with cardiac disease revealed their substantial denervation compared with controls. Spatial, single-cell, nuclear, and bulk RNA sequencing traced this defect back to the superior cervical ganglia (SCG), which responded to cardiac disease with accumulation of inflammatory macrophages, fibrosis, and the selective loss of pineal gland–innervating neurons. Depletion of macrophages in the SCG prevented disease-associated denervation of the pineal gland and restored physiological melatonin secretion. Our data identify the mechanism by which diurnal rhythmicity in cardiac disease is disturbed and suggest a target for therapeutic intervention.

multidisciplinary sciences
Sleep in heart failure

Matthew T Naughton,Geraldo Lorenzi-Filho

DOI: https://doi.org/10.1016/j.pcad.2008.02.001

Abstract:Sleep plays a large role in patients with heart failure. In normal subjects, sleep is usually in a supine position with reduced sympathetic drive, elevated vagal tone and as such a relatively lower cardiac output and minute ventilation, allowing for recuperation. Patients with heart failure may not experience the same degree of autonomic activity change and the supine position may place a large strain on the pulmonary system. More than half of all heart failure patients have one of two types of sleep apnea: either obstructive or central sleep apnea. Some patients have both types. Obstructive sleep apnea is likely to be a cause of heart failure due to large negative intrathoracic pressures, apnea related hypoxemia and hypercapnia, terminated by an arousal and surge in systemic blood pressure associated with endothelial damage and resultant premature atherosclerosis. Reversal of obstructive sleep apnea improves blood pressure, systolic contraction and autonomic dysfunction however mortality studies are lacking. Central sleep apnea with Cheyne Stokes pattern of respiration (CSA-CSR) occurs as a result of increased central controller (brainstem driving ventilation) and plant (ventilation driving CO2) gain in the setting of a delayed feed back (i.e., low cardiac output). It is thought this type of apnea is a result of moderately to severely impaired cardiac function and is possibly indicative of high mortality. Treatment of CSA-CSR is best undertaken by treating the underlying cardiac condition which may include with medications, pacemakers, transplantation or continuous positive airway pressure (CPAP). In such patients CPAP exerts unique effects to assist cardiac function and reduce pulmonary edema. Whether CPAP improves survival in this heart failure population remains to be determined.
Sleep modulates haematopoiesis and protects against atherosclerosis

Cameron S McAlpine,Máté G Kiss,Sara Rattik,Shun He,Anne Vassalli,Colin Valet,Atsushi Anzai,Christopher T Chan,John E Mindur,Florian Kahles,Wolfram C Poller,Vanessa Frodermann,Ashley M Fenn,Annemijn F Gregory,Lennard Halle,Yoshiko Iwamoto,Friedrich F Hoyer,Christoph J Binder,Peter Libby,Mehdi Tafti,Thomas E Scammell,Matthias Nahrendorf,Filip K Swirski

DOI: https://doi.org/10.1038/s41586-019-0948-2

IF: 64.8

Nature

Abstract:Sleep is integral to life1. Although insufficient or disrupted sleep increases the risk of multiple pathological conditions, including cardiovascular disease2, we know little about the cellular and molecular mechanisms by which sleep maintains cardiovascular health. Here we report that sleep regulates haematopoiesis and protects against atherosclerosis in mice. We show that mice subjected to sleep fragmentation produce more Ly-6Chigh monocytes, develop larger atherosclerotic lesions and produce less hypocretin-a stimulatory and wake-promoting neuropeptide-in the lateral hypothalamus. Hypocretin controls myelopoiesis by restricting the production of CSF1 by hypocretin-receptor-expressing pre-neutrophils in the bone marrow. Whereas hypocretin-null and haematopoietic hypocretin-receptor-null mice develop monocytosis and accelerated atherosclerosis, sleep-fragmented mice with either haematopoietic CSF1 deficiency or hypocretin supplementation have reduced numbers of circulating monocytes and smaller atherosclerotic lesions. Together, these results identify a neuro-immune axis that links sleep to haematopoiesis and atherosclerosis.
Light exposure during sleep impairs cardiometabolic function

Ivy C. Mason,Daniela Grimaldi,Kathryn J. Reid,Chloe D. Warlick,Roneil G. Malkani,Sabra M. Abbott,Phyllis C. Zee

DOI: https://doi.org/10.1073/pnas.2113290119

IF: 11.1

2022-03-14

Proceedings of the National Academy of Sciences

Abstract:Significance Ambient nighttime light exposure is implicated as a risk factor for adverse health outcomes, including cardiometabolic disease. However, the effects of nighttime light exposure during sleep on cardiometabolic outcomes and the related mechanisms are unclear. This laboratory study shows that, in healthy adults, one night of moderate (100 lx) light exposure during sleep increases nighttime heart rate, decreases heart rate variability (higher sympathovagal balance), and increases next-morning insulin resistance when compared to sleep in a dimly lit (<3 lx) environment. Moreover, a positive relationship between higher sympathovagal balance and insulin levels suggests that sympathetic activation may play a role in the observed light-induced changes in insulin sensitivity.
Sleep disorders in patients with heart diseases - present knowledge

K Malewicz,J Grzebieluch,A Felinczak

DOI: https://doi.org/10.1093/eurjcn/zvae098.106

2024-07-01

European Journal of Cardiovascular Nursing

Abstract:Abstract Introduction The problem of sleep disorders plays a significant role in the functioning of people in the contemporary world, particularly affecting cardiac patients. It entails a series of consequences that impact health. The study analyzed the occurrence of sleep disorders among cardiac patients. Purpose The project aimed to assess the available literature regarding described sleep disorders in patients with cardiovascular diseases and to analyze the impact of sleep disorders on the functioning of cardiac patients. Methods Materials available in PubMed and Google Scholar were analyzed using keywords such as "sleep disorders," "insomnia," "cardiovascular disease," "heart attack," "heart failure," "hypertension," "coronary artery disease" in various configurations. A comprehensive analysis of publications was conducted to identify studies on sleep disorders in cardiac patients, focusing on risk factors and management strategies for sleep problems in this patient group. Results Sleep disorders occur in cardiac patients and significantly affect their health. Sleep disorders also increase cardiovascular risk in healthy individuals. Sleep disorder management methods include problem recognition, lifestyle modifications, pharmacotherapy, and behavioral interventions. A crucial aspect of care appears to be the need for diagnosing sleep problems in cardiac patients and implementing integrated multidisciplinary care. Conclusions Sleep disorders pose a significant risk for cardiac patients, requiring an interdisciplinary therapeutic approach. Future research should assess the scale of sleep disorders in cardiac patients in Poland, as well as identify factors influencing sleep disorders in this patient group. Subsequently, treatment strategies and integrated care should be developed.

nursing,cardiac & cardiovascular systems
Sleep Abnormalities Among Community Participants At Risk For Heart Failure

Yogesh N.V. Reddy,Susan DeFranco,John Park,Amir Lerman,Virend Somers,Barry Borlaug

DOI: https://doi.org/10.1016/j.cardfail.2023.10.044

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Introduction Sleep abnormalities are associated with metabolic health and underlying heart failure (HF). HF with preserved Ejection Fraction (HFpEF) is the most common cause of HF but is severely underdiagnosed given the limitations in current diagnostic criteria. Therefore, we sought to determine self-reported and directly recorded sleep abnormalities using custom fitted beds capable of physiological monitoring (SleepNumber Co) among community-dwelling participants who were at risk of HFpEF. Methods We first developed a regression equation to estimate the probability of HFpEF using age and body mass index in a derivation cohort where the diagnosis of HFpEF was definitively confirmed or refuted conclusively using gold standard diagnosis with exercise right heart catheterization demonstrating elevated exercise pulmonary capillary wedge pressure. This was validated in an independent cohort with similar gold standard diagnosis. We then estimated the probability of HFpEF in community participants at risk for HFpEF and compared directly recorded sleep data averaged over a month of observation in 91954 Sleep Number bed users, as well as self reported Sleep survey data in a subset (n=5861) of these participants. Results The HFpEF prediction algorithm based on age and BMI had good discrimination in the derivation (AUC 0.806 [95% CI 0.761-0.850], p<0.0001) and validation cohort (AUC 0.770 [95% CI 0.730-0.810], p<0.0001). Comparing individuals with a high probability (>75%) of HFpEF (HFpEFhighprob) with those with a low probability (<25%) of HFpEF (HFpEFlowprob), those with HFpEFhighprob were more likely to report taking regular naps during the day (16.4% vs 11.2%, p<0.0001) and never exercise (24.4 vs 17.7%, p<0.0001). The HFpEFhighprob group were also more likely to have self-reported sleep disturbances 7 days a week (36% vs 19%, p<0.0001), nocturia requiring awakening at night (69% vs 45%, p<0.0001), and sleep problems present for more than a year (76% vs 64%, p<0.0001). These sleep disturbances in HFpEFhighprob occurred despite a lower proportion reporting difficulty falling asleep (31% vs 40%, p<0.0001), similar objectively measured average hours slept across groups (median 8.4 [IQR 7.0-10.3] vs 8.6 hours [7.2-10.3], p=0.11) and less awakening episodes per night (median 3 [IQR 3-5] vs 4 [3-5], p=0.0003) suggesting impaired quality of sleep rather than duration. The HFpEFhighprob also demonstrated greater fluctuations in peak and trough sleep motion, respiration and HR indices, and greater HR variability throughout sleeping sessions (p<0.0001 for all) compared to HFpEFlowprob. Conclusion Self reported and objective sleep abnormalities in physiological indices and quality of sleep are commonly observed in community participants at high risk for HFpEF. Given the impaired quality of life in HFpEF, further study of the true prevalence and impact of sleep disorders in HFpEF are urgently needed.

cardiac & cardiovascular systems
Chronic sleep fragmentation reduces left ventricular contractile function and alters gene expression related to innate immune response and circadian rhythm in the mouse heart

Ling Zhong,Jie Zhang,Jielin Yang,Bo Li,Xinghao Yi,John R Speakman,Shan Gao,Ming Li,John R. Speakman

DOI: https://doi.org/10.1016/j.gene.2024.148420

IF: 3.913

2024-07-01

Gene

Abstract:Sleep disorders have emerged as a widespread public health concern, primarily due to their association with an increased risk of developing cardiovascular diseases. Our previous research indicated a potential direct impact of insufficient sleep duration on cardiac remodeling in children and adolescents. Nevertheless, the underlying mechanisms behind the link between sleep fragmentation (SF) and cardiac abnormalities remain unclear. In this study, we aimed to investigate the effects of SF interventions at various life stages on cardiac structure and function, as well as to identify genes associated with SF-induced cardiac dysfunction. To achieve this, we established mouse models of chronic SF and two-week sleep recovery (SR).Our results revealed that chronic SF significantly compromised left ventricular contractile function across different life stages, leading to alterations in cardiac structure and ventricular remodeling, particularly during early life stages. Moreover, microarray analysis of mouse heart tissue identified two significant modules and nine hub genes (Ddx60, Irf9, Oasl2, Rnf213, Cmpk2, Stat2, Parp14, Gbp3, and Herc6) through protein-protein interaction analysis. Notably, the interactome predominantly involved innate immune responses. Importantly, all hub genes lost significance following SR. The second module primarily consisted of circadian clock genes, and real-time PCR validation demonstrated significant upregulation of Arntl, Dbp, and Cry1 after SF, while subsequent SR restored normal Arntl expression. Furthermore, the expression levels of four hub genes (Ddx60, Irf9, Oasl2, and Cmpk2) and three circadian clock genes (Arntl, Dbp, and Cry1) exhibited correlations with structural and functional echocardiographic parameters.Overall, our findings suggest that SF impairs left ventricular contractile function and ventricular remodeling during early life stages, and this may be mediated by modulation of the innate immune response and circadian rhythm. Importantly, our findings suggest that a short period of SR can alleviate the detrimental effects of SF on the cardiac immune response, while the influence of SF on circadian rhythm appears to be more persistent. These findings underscore the importance of adequate sleep duration for maintaining cardiac health, particularly during early life stages.

genetics & heredity
Sleep and sleep disturbances: biological basis and clinical implications

N. Zisapel

DOI: https://doi.org/10.1007/s00018-007-6529-9

IF: 8

2007-03-15

Cellular and Molecular Life Sciences

Abstract:Abstract.Sleep is a neurochemical process involving sleep promoting and arousal centers in the brain. Sleep performs an essential restorative function and facilitates memory consolidation in humans. The remarkably standardized bouts of consolidated sleep at night and daytime wakefulness reflect an interaction between the homeostatic sleep need that is manifested by increase in sleep propensity after sleep deprivation and decrease during sleep and the circadian pacemaker. Melatonin, the hormone produced nocturnally by the pineal gland, serves as a time cue and sleep-anticipating signal. A close interaction exists between the sleep-wake, melatonin, core temperature, blood pressure, immune and hormonal rhythms leading to optimization of the internal temporal order. With age the robustness of the circadian system decreases and the prevalence of sleep disorders, particularly insomnia, increases. Deviant sleep patterns are associated with increased risks of morbidity, poor quality of life and mortality. Current sleep pharmacotherapies treat insufficient sleep quantity, but fail to improve daytime functioning. New treatment modalities for sleep disorders that will also improve daytime functioning remain a scientific and medical challenge.

cell biology,biochemistry & molecular biology
Abstract P165: Cardiac Capillary Pericytes Constriction Mediates Sleep Deprivation Induced Coronary Microcirculation Dysfunction

Chao Wu,Ziyu Guo,Yimin Tu,Yaxin Wu,Qing Li,Xiaozhai Yu,Yike Li,Changan Yu,Yi Fu,Yanxiang Gao,Wei Kong,Jingang Zheng

DOI: https://doi.org/10.1161/atvb.41.suppl_1.p165

2021-01-01

Arteriosclerosis Thrombosis and Vascular Biology

Abstract:Background: Lack of sleep can lead to a variety of adverse cardiovascular events and even sudden death. In most cases, there is no obstructive coronary artery. Coronary microcirculation dysfunction (CMD) is thereby thought to play an important role in cardiovascular events caused by sleep loss. Pericytes regulate blood flow and mediate neurovascular signaling in brain. Here, we hypothesized that cardiac capillary pericytes mediate sleep loss related CMD. Methods and Results: Eight-week-old male C57BL/6J mice were deprived sleep for 6 hours or 72 hours. Cardiac function was detected by transthoracic echocardiography before and after sleep deprivation (SD). Vascular endothelial dyes were perfusion before tissue harvest to evaluate cardiac perfusion. By whole heart clearing, 3D immunolabeling and imaging, the effect of pericytes on cardiac capillary was accessed. Acute 6-hours total sleep deprivation or 72-hours severe sleep deprivation led to decreased cardiac systolic and diastolic dysfunction. Left ventricular end diastolic diameter and left ventricular end systolic diameter increased by 10.12% (0.32 mm of 3.14 mm) and 19.00% (0.31 mm of 1.63 mm). Although coronary flow velocity reserve showed no differences between sleep deprivation and control groups, the basal and maximum coronary blood velocity were increased in acute and severe total sleep deprivation mice, which illustrated CMD. Compared with mice in the control group, the area of cardiac perfusion in the sleep deprivation group was significantly reduced (33.42 ± 4.30% vs. 53.81 ± 7.42%, P < 0.05; SD group, n=7; control group, n=6). Whole mount heart imaging showed pericytes were widely distributed around the microvascular, without difference in regional distribution in the heart. In the area of cardiac perfusion defect, capillary blockages colocalized with pericytes, and the capillary diameter at the pericyte body was significantly reduced in sleep deprived mice (2.01 ± 0.12 μm vs. 2.92 ± 0.07 μm, P < 0.05; SD group, n=10; control group, n=10). Conclusion: Sleep restriction led to cardiac dysfunction and CMD, that pericytes mediated contraction of capillaries might contribute to the process. Cardiac pericytes would be a novel therapeutic target in sleep loss associated heart disease.
Effect of selective sleep deprivation on heart rate variability in post-90s healthy volunteers

Fengjuan Liu,Binbin Qu,Lili Wang,Yahui Xu,Xiufa Peng,Chunling Zhang,Dexiang Xu

DOI: https://doi.org/10.3934/mbe.2022645

2022-09-19

Abstract:The 5-minute frequency domain method was used to examine the effects of polysomnography (PSG)-guided acute selective sleep deprivation (REM/SWS) on the cardiovascular autonomic nervous system, heart rate, and rhythm in healthy volunteers to understand the relationship between cardiac neuro regulatory homeostasis and cardiovascular system diseases in healthy subjects. The study included 30 healthy volunteers selected through the randomized-controlled method, randomly divided into REM sleep deprivation and SWS sleep deprivation groups. PSG analyses and dynamic electrocardiogram monitoring were done at night, during slow wave sleep or REM sleep. An all-night sleep paradigm, without any interruptions, was tested 3 times for comparison. The frequency domain parameter method was further used to monitor the volunteers 5 min before and after a period of sleep deprivation. According to the characteristics of the all-night sleep scatter plot, healthy volunteers were divided into abnormal and normal scatter plot groups. When compared with the period before sleep deprivation, high frequency (HF) and normalized high-frequency component (HFnu) were found to be decreased. Normalized low-frequency component (LFnu) increased in the abnormal scatter plot group after sleep deprivation, and this difference was statistically significant (P < 0.05). The scatter plot also showed that very low frequency (VLF) increased only in the normal group after deprivation and this difference, as well, was statistically significant (P < 0.05). The increase in diastolic blood pressure in the abnormal group was statistically significant (P < 0.05), but the change in blood pressure in the normal group was not statistically significant (P > 0.05). There are 62.5% of the patients and 20% of the employees that were observed to have abnormal whole-night sleep patterns during the uninterrupted whole-night sleep regime. Patients with atrial or ventricular premature beats (more than 0.1%), and those with ST-t changes during sleep, were all ascertained as abnormal. We concluded that some healthy people could face unstable autonomic nervous functioning related to their long-term tension, anxiety, time urgency, hostility, and other chronic stress states. In the face of acute sleep deprivation selectivity, mild stress based excitability of the vagus nerve is reduced, which diminishes the protective function, making them susceptible to conditions such as premature ventricular arrhythmia.
Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin

Clayton Vasey,Jennifer McBride,Kayla Penta

DOI: https://doi.org/10.3390/nu13103480

IF: 5.9

2021-09-30

Nutrients

Abstract:Sleep is an essential component of overall human health but is so tightly regulated that when disrupted can cause or worsen certain ailments. An important part of this process is the presence of the well-known hormone, melatonin. This compound assists in the governing of sleep and circadian rhythms. Previous studies have postulated that dysregulation of melatonin rhythms is the driving force behind sleep and circadian disorders. A computer-aided search spanning the years of 2015–2020 using the search terms melatonin, circadian rhythm, disorder yielded 52 full text articles that were analyzed. We explored the mechanisms behind melatonin dysregulation and how it affects various disorders. Additionally, we examined associated therapeutic treatments including bright light therapy (BLT) and exogenous forms of melatonin. We found that over the past 5 years, melatonin has not been widely investigated in clinical studies thus there remains large gaps in its potential utilization as a therapy.

nutrition & dietetics
Spontaneous attentional failures reflect multiplicative interactions of chronic sleep loss with acute sleep loss and circadian misalignment

Daniel Aeschbach,Daniel A Cohen,Brandon J Lockyer,Sarah L Chellappa,Elizabeth B Klerman

DOI: https://doi.org/10.1016/j.sleh.2023.07.013

IF: 4.207

Sleep Health

Abstract:Objectives: Acute and chronic sleep loss and circadian timing interact such that, depending on their combination, small or very large performance decrements are observed in tasks of attention. Here, we tested whether such nonlinear interactions extend to a physiological measure of spontaneous visual attentional failures, indicating a fundamental principle of sleep-wake regulation. Methods: Nine healthy volunteers completed an in-laboratory 3-week forced desynchrony protocol consisting of 12 consecutive 42.85-hour cycles with a sleep-wake ratio of 1:3.3. The protocol induced increasing chronic sleep loss, while extended wake (32.85 hours) and sleep episodes (10 hours) occurred at multiple circadian phases. Attentional failure rate was quantified from continuous electrooculograms (number of 30-second epochs with slow eye movements/h of wakefulness) as a function of time since scheduled wake (acute sleep loss), week of study (chronic sleep loss), and circadian (melatonin) phase. Results: During the first ∼8 hours awake, attentional failure rate was low, irrespective of the week. During the following wake hours, attentional failure rate increased steadily but at a faster rate in weeks 2 and 3 compared to week 1. The effects of acute and chronic sleep loss on attentional failure rate were magnified during the biological night compared to the biological day. Conclusions: A single extended sleep episode can only temporarily reverse attentional impairment associated with chronic sleep loss. Multiplicative effects of acute and chronic sleep loss-further amplified during the biological night-substantiate the interaction of 2 homeostatic response mechanisms and caution against underestimating their disproportionate combined impact on performance, health, and safety.
Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction

Yuan Liu,Li-Na Li,Sen Guo,Xiao-Yan Zhao,Yu-Zhou Liu,Cui Liang,Sheng Tu,Dan Wang,Ling Li,Jian-Zeng Dong,Lu Gao,Hai-Bo Yang

DOI: https://doi.org/10.1016/j.redox.2018.07.007

IF: 11.4

2018-09-01

Redox Biology

Abstract:Melatonin has been shown to inhibit myocardial infarction-induced apoptosis, its function in heart failure with preserved ejection fraction (HFpEF) has not been investigated. This study aimed to investigate whether melatonin attenuates obesity-related HFpEF. Male mice were fed a high-fat diet (HFD) from weaning to 6 months of age to induce HFpEF. The mice were orally administered melatonin (50 mg/kg) by 3 weeks. Diastolic function was significantly improved by melatonin supplementation in mice fed an HFD. Melatonin attenuated obesity-induced myocardial oxidative stress and apoptosis and promoted the secretion of C1q/tumour necrosis factor-related protein 3 (CTRP3) by adipose tissue. And depletion of circulating CTRP3 largely abolished melatonin-mediated cardio-protection. Melatonin-mediated secretion of adipocyte-derived CTRP3 activated NF-E2-related factor 2 (Nrf2), which were largely abrogated by knocking down CTRP3 in adipocytes or Nrf2 in cardiomyocytes. Nrf2 activation was mediated by miR-200a, and a miR-200a antagomir offset the effects of melatonin-conditioned medium on Nrf2 expression. Our results indicate that melatonin can be used to treat and prevent obesity-related HFpEF.

biochemistry & molecular biology
Melatonin and circadian biology in human cardiovascular disease

Alberto Dominguez‐Rodriguez,Pedro Abreu‐Gonzalez,Juan J. Sanchez‐Sanchez,Juan C. Kaski,Russel J. Reiter,Alberto Dominguez-Rodriguez,Pedro Abreu-Gonzalez,Juan J. Sanchez-Sanchez

DOI: https://doi.org/10.1111/j.1600-079x.2010.00773.x

2010-05-01

Journal of Pineal Research

Abstract:Diurnal rhythms influence cardiovascular physiology, i.e. heart rate and blood pressure, and they appear to also modulate the incidence of serious adverse cardiac events. Diurnal variations occur also at the molecular level including changes in gene expression in the heart and blood vessels. Moreover, the risk/benefit ratio of some therapeutic strategies and the concentration of circulating cardiovascular system biomarkers may also vary across the 24-hr light/dark cycle. Synchrony between external and internal diurnal rhythms and harmony among molecular rhythms within the cell are essential for normal organ biology. Diurnal variations in the responsiveness of the cardiovascular system to environmental stimuli are mediated by a complex interplay between extracellular (i.e. neurohumoral factors) and intracellular (i.e. specific genes that are differentially light/dark regulated) mechanisms. Neurohormones, which are particularly relevant to the cardiovascular system, such as melatonin, exhibit a diurnal variation and may play a role in the synchronization of molecular circadian clocks in the peripheral tissue and the suprachiasmatic nucleus. Moreover, mounting evidence reveals that the blood melatonin rhythm has a crucial role in several cardiovascular functions, including daily variations in blood pressure. Melatonin has antioxidant, anti-inflammatory, chronobiotic and, possibly, epigenetic regulatory functions. This article reviews current knowledge related to the biological role of melatonin and its circadian rhythm in cardiovascular disease.

neurosciences,endocrinology & metabolism,physiology
The chronobiology of human heart failure: clinical implications and therapeutic opportunities

Francesco Gentile,Michele Emdin,Claudio Passino,Sabrina Montuoro,Paola Tognini,John S. Floras,John O’Neill,Alberto Giannoni

DOI: https://doi.org/10.1007/s10741-024-10447-1

2024-10-13

Heart Failure Reviews

Abstract:Circadian variation in cardiovascular and metabolic dynamics arises from interactions between intrinsic rhythms and extrinsic cues. By anticipating and accommodating adaptation to awakening and activity, their synthesis maintains homeostasis and maximizes efficiency, flexibility, and resilience. The dyssynchrony of cardiovascular load and energetic capacity arising from attenuation or loss of such rhythms is strongly associated with incident heart failure (HF). Once established, molecular, neurohormonal, and metabolic rhythms are frequently misaligned with each other and with extrinsic cycles, contributing to HF progression and adverse outcomes. Realignment of biological rhythms via lifestyle interventions, chronotherapy, and time-tailored autonomic modulation represents an appealing potential strategy for improving HF-related morbidity and mortality.

cardiac & cardiovascular systems
Sleep-induced hypotension precipitates severe myocardial ischemia

Song-Jung Kim,Alex Kuklov,Richard F Kehoe,George J Crystal

IF: 6.313

SLEEP

Abstract:Study objectives: Epidemiologic studies have shown a high frequency of major cardiac events at night in patients with coronary artery disease. This has been attributed to the sympathetic surges accompanying rapid eye movement (REM) sleep; the role of non-REM sleep, which comprises 80% of total sleep duration, has been largely neglected. Accordingly, we evaluated the effect of non-REM sleep on contractile function in a region of the left ventricular wall supplied by a flow-limiting coronary stenosis. Design: Eight domestic pigs were chronically instrumented to measure regional left ventricular contractile function (wall thickening), coronary blood flow, and systemic hemodynamic variables. Measurements were obtained: (1) during wakefulness, i.e., conscious condition, prior to imposition of coronary stenosis; (2) during wakefulness following imposition of coronary stenosis (30% reduction of baseline coronary blood flow from 40 +/- 4 to 27 +/- 3 mL/min); and (3) during non-REM sleep with coronary stenosis maintained. Results: During wakefulness, coronary stenosis reduced wall thickening (from 23.3 +/- 3.4% to 15.7 +/- 2.0%), whereas mean arterial pressure and heart rate were unchanged. With coronary stenosis maintained, the onset of non-REM sleep caused 20% decreases in mean arterial pressure and coronary blood flow, accompanied by a cessation of regional wall thickening, i.e., akinesis (wall thickening = 0.2 +/- 2.8%), indicating severe myocardial ischemia. Conclusions: The arterial hypotension, and associated reduction in coronary blood flow, during non-REM sleep precipitated severe myocardial ischemia in a region of the left ventricular wall supplied by flow-limiting coronary stenosis. Such episodes would occur repeatedly during the sleep cycle and could potentially set the stage for a major cardiac event during the sympathetic activation accompanying REM sleep or morning activities.
Heart rate variability during slow wave sleep is linked to functional connectivity in the central autonomic network

Shawn D X Kong,Christopher J Gordon,Camilla M Hoyos,Rick Wassing,Loren Mowszowski,Catriona Ireland,Jake R Palmer,Ronald R Grunstein,James M Shine,Andrew C McKinnon,Sharon L Naismith,Angela D’Rozario

DOI: https://doi.org/10.1093/braincomms/fcad129

2023-01-01

Brain Communications

Abstract:Abstract Reduced heart rate variability can be an early sign of autonomic dysfunction in neurodegenerative diseases and may be related to brain dysfunction in the central autonomic network. As yet, such autonomic dysfunction has not been examined during sleep—which is an ideal physiological state to study brain–heart interaction as both the central and peripheral nervous systems behave differently compared to during wakefulness. Therefore, the primary aim of the current study was to examine whether heart rate variability during nocturnal sleep, specifically slow wave (deep) sleep, is associated with central autonomic network functional connectivity in older adults ‘at-risk’ of dementia. Older adults (n = 78; age range = 50–88 years; 64% female) attending a memory clinic for cognitive concerns underwent resting-state functional magnetic resonance imaging and an overnight polysomnography. From these, central autonomic network functional connectivity strength and heart rate variability data during sleep were derived, respectively. High-frequency heart rate variability was extracted to index parasympathetic activity during distinct periods of sleep, including slow wave sleep as well as secondary outcomes of non-rapid eye movement sleep, wake after sleep onset, and rapid eye movement sleep. General linear models were used to examine associations between central autonomic network functional connectivity and high-frequency heart rate variability. Analyses revealed that increased high-frequency heart rate variability during slow wave sleep was associated with stronger functional connectivity (F = 3.98, P = 0.022) in two core brain regions within the central autonomic network, the right anterior insular and posterior midcingulate cortex, as well as stronger functional connectivity (F = 6.21, P = 0.005) between broader central autonomic network brain regions—the right amygdala with three sub-nuclei of the thalamus. There were no significant associations between high-frequency heart rate variability and central autonomic network connectivity during wake after sleep onset or rapid eye movement sleep. These findings show that in older adults ‘at-risk’ of dementia, parasympathetic regulation during slow wave sleep is uniquely linked to differential functional connectivity within both core and broader central autonomic network brain regions. It is possible that dysfunctional brain–heart interactions manifest primarily during this specific period of sleep known for its role in memory and metabolic clearance. Further studies elucidating the pathophysiology and directionality of this relationship should be conducted to determine if heart rate variability drives neurodegeneration, or if brain degeneration within the central autonomic network promotes aberrant heart rate variability.
New insights into the role of melatonin in diabetic cardiomyopathy

Keming Huang,Xianling Luo,Yi Zhong,Li Deng,Jian Feng

DOI: https://doi.org/10.1002/prp2.904

2022-01-10

Abstract:Diabetic cardiovascular complications and impaired cardiac function are considered to be the main causes of death in diabetic patients worldwide, especially patients with type 2 diabetes mellitus (T2DM). An increasing number of studies have shown that melatonin, as the main product secreted by the pineal gland, plays a vital role in the occurrence and development of diabetes. Melatonin improves myocardial cell metabolism, reduces vascular endothelial cell death, reverses microcirculation disorders, reduces myocardial fibrosis, reduces oxidative and endoplasmic reticulum stress, regulates cell autophagy and apoptosis, and improves mitochondrial function, all of which are the characteristics of diabetic cardiomyopathy (DCM). This review focuses on the role of melatonin in DCM. We also discuss new molecular findings that might facilitate a better understanding of the underlying mechanism. Finally, we propose potential new therapeutic strategies for patients with T2DM.

pharmacology & pharmacy
Poor Sleep Quality And Excessive Daytime Sleepiness Are Associated With Adverse Health Outcomes In Patients With Heart Failure

Jia-Rong Wu,Chin-Yen Lin,Terry Lennie,Debra Moser

DOI: https://doi.org/10.1016/j.cardfail.2023.10.230

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Background Poor sleep quality is common among patients with heart failure (HF), and results in excessive daytime sleepiness. Both poor sleep quality and excessive daytime sleepiness are associated with poor health outcomes, but the extent to which this relationship exists in patients with HF is unknown. Objective To explore the associations among sleep quality, excessive daytime sleepiness, and cardiac event-free survival in patients with HF. Method This was a prospective, longitudinal study of 210 patients with HF (female 33%, age 62±12, ischemic HF: 45%, NYHA class III/IV: 37%). Sleep quality was measured using the Pittsburg Sleep Quality Index. Daytime sleepiness was measured by the Epworth Sleepiness Scale. HF hospitalizations and cardiac mortality were followed at least one year and obtained by patient interview, medical record review, and death certificate review. Chi-square, ANOVA, logistic regression, and survival analyses (i.e., Kaplan-Meier with log rank tests and Cox regression) were used for data analysis. Results One hundred and twelve patients (53%) had poorer sleep quality. Sixty-four patients (31%) had excessive daytime sleepiness. Compared to those with better sleep quality, patients with poorer sleep quality were 2.3 times more likely to have excessive daytime sleepiness (P =.008). Patients were divided into 4 groups based on sleep quality and daytime sleepiness: 1) better sleep quality without excessive daytime sleepiness; 2) better sleep quality with excessive daytime sleepiness; 3) poorer sleep quality without excessive daytime sleepiness; and 4) poorer sleep quality with excessive daytime sleepiness. Both poorer sleep quality and excessive daytime sleepiness independently predicted worse cardiac event-free survival (both P < .05). Cardiac event-free survival was worst in those with both poorer sleep quality and excessive daytime sleepiness compared to patients in any of the other three groups. Patients with poorer sleep quality and excessive daytime sleepiness had 3.3 times higher risk of a cardiac event compared to those with better sleep quality or without excessive daytime sleepiness (P = .004, Figure). Race and New York Heart Association functional class (NYHA) were significantly different among the four sleep quality and daytime sleepiness groups. Conclusion Patients with poorer sleep quality and excessive daytime sleepiness were at highest risk of experiencing a cardiac event. Patients with HF need to be screened for their sleep problems and interventions need to be developed to target high risk patients with poor sleep quality and excessive daytime sleepiness to alleviate poor outcomes in patients with HF.

cardiac & cardiovascular systems
0741 Effects of Light Exposure on Sleep, Rest-Activity Rhythms, and Cognitive Function in Adults with Heart Failure

Zequan Wang,Sangchoon Jeon,Samantha Conley,Kelley LaFleur,Nancy Redeker

DOI: https://doi.org/10.1093/sleep/zsae067.0741

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Sleep disturbance and circadian rhythm disruptions are common among adults with chronic heart failure (HF), and are related to cognitive impairment. Although light levels are known to influence sleep quality, cognition, and the circadian system, little is known about the role of light among adults with HF. The purpose of this study is to investigate the association between light exposure and sleep, diurnal rest-activity rhythms (RAR), and cognitive function among adults with HF. Methods We retrospectively analyzed baseline data from a randomized controlled trial of cognitive behavioral therapy for insomnia for adults with HF and insomnia. We measured light levels and sleep with 24-hour wrist actigraphy and computed the circadian quotient, inter-daily stability, and intra-daily variability (strength of the RAR) using cosinor and non-parametric methods. We computed time above threshold (TAT) (100, 500, and 1000 lux), ratio of light exposure in daytime to evening (AUC ratio), and light regularity index (LRI) (20, 50, and 100 lux) to assess the intensity and consistency of light exposure patterns. Lapses in performance on the Psychomotor Vigilance Task (PVT lapse) measured cognitive function. Multiple linear regressions tested if the light exposure metrics could predict the RAR, sleep efficiency, and PVT lapses after adjusting for age, sex, and comorbidities. Results The sample included 167 participants (M age=63.8 (SD =12.9) years; 45.5%female). The AUC ratio and TAT500 were associated with a stronger circadian quotient in males (0.339 ± 0.095, p=.0005; 0.296 ± 0.085, p=.0006) compared to females (0.058 ± 0.106, p=.5800; -0.061 ± 0.128, p=.6364), after controlling for age and comorbidities. TAT500 was associated with better inter-daily stability (0.221 ± 0.077, p=.0044) than the other thresholds. Higher light exposure intensity (TAT100) (0.129 ± 0.065, p=.0492) and a greater circadian quotient (0.267±0.076, p=.0006) were associated with improved sleep efficiency. TAT100 was associated with fewer PVT lapses (-0.229 ± 0.082, p=.0061), after controlling for total sleep time, circadian quotient, and demographics. Conclusion Light exposure, particularly at certain intensities and regularity, predicted RARs, sleep efficiency, and cognitive function in adults with HF. Future tailored light interventions with varying intensities and regularity may improve HF outcomes. Support (if any)

neurosciences,clinical neurology

Heart failure causes sleepless nights

Immune-mediated denervation of the pineal gland underlies sleep disturbance in cardiac disease

Sleep in heart failure

Sleep modulates haematopoiesis and protects against atherosclerosis

Light exposure during sleep impairs cardiometabolic function

Sleep disorders in patients with heart diseases - present knowledge

Sleep Abnormalities Among Community Participants At Risk For Heart Failure

Chronic sleep fragmentation reduces left ventricular contractile function and alters gene expression related to innate immune response and circadian rhythm in the mouse heart

Sleep and sleep disturbances: biological basis and clinical implications

Abstract P165: Cardiac Capillary Pericytes Constriction Mediates Sleep Deprivation Induced Coronary Microcirculation Dysfunction

Effect of selective sleep deprivation on heart rate variability in post-90s healthy volunteers

Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin

Spontaneous attentional failures reflect multiplicative interactions of chronic sleep loss with acute sleep loss and circadian misalignment

Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction

Melatonin and circadian biology in human cardiovascular disease

The chronobiology of human heart failure: clinical implications and therapeutic opportunities

Sleep-induced hypotension precipitates severe myocardial ischemia

Heart rate variability during slow wave sleep is linked to functional connectivity in the central autonomic network

New insights into the role of melatonin in diabetic cardiomyopathy

Poor Sleep Quality And Excessive Daytime Sleepiness Are Associated With Adverse Health Outcomes In Patients With Heart Failure

0741 Effects of Light Exposure on Sleep, Rest-Activity Rhythms, and Cognitive Function in Adults with Heart Failure